47% of clinical quality organizations have no AI use today.
What's holding the industry back, and what do you need to move forward?
We surveyed QA leaders, clinical operations professionals, and regulatory experts across CROs, sponsors, and sites in North America and Europe. The results reveal where the industry actually stands on AI adoption in quality management.
You'll find out:
- Why regulatory uncertainty is the number 1 barrier to AI adoption, cited by 32% of respondents
- Where organizations are applying AI today (and why document review and SOP optimization top the list)
- Why 48.5% of organizations have no clear owner for AI governance
- How QA professionals expect their roles to shift in the next 3-5 years
- What your team needs to do now to move forward without falling behind
"Critical thinking should dominate all that we do in both QA and the functions we support. AI has tremendous potential; however, it will not eliminate the need for a person to review the outputs and ensure that they make sense"
Dawn Niccum, Executive Vice President, QA, Just In Time GCP
